Table 1.
Classification of the FNA results, surgeries indicated and performed, and histology of the surgical specimen according to the cytologic category in the period 2006–2008; to TBSRTC 2009 in the period 2012–2014; and to the TBSRTC 2017 in the period 2017–2019. Data are presented as n (%).
Total FNA | Total FNA with surgery indicated | Total FNA with surgery performed | Benign histology | Malignant histology | NIFTP | |
---|---|---|---|---|---|---|
Cytologic category (2006–2008) | NA | |||||
Benign | 587 (82.4) | 97 (16.5) | 84 (14.3) | 82 (97.6) | 2 (2.4) | |
FP | 52 (7.3) | 33 (63.5) | 30 (57.7) | 29 (96.7) | 1 (3.3) | |
FP atypia | 61 (8.6) | 61 (100) | 56 (91.8) | 45 (80.4) | 11 (19.6) | |
Malignant | 12 (1.7) | 12 (100) | 12 (100) | 1 (8.3) | 11 (91.6) | |
Total | 712 (100) | 203 (28.5) | 182 (25.6) | 157 (86.3) | 25 (13.7) | |
TBSRTC 2009 (2012–2014) | NA | |||||
II | 735 (87.5) | 100 (13.6) | 79 (10.7) | 76 (96.2) | 3 (3.8) | |
III | 56 (6.7) | 48 (85.7) | 44 (78.6) | 35 (79.5) | 9 (20.5) | |
IV | 16 (1.9) | 16 (100) | 16 (100) | 9 (56.2) | 7 (43.8) | |
V | 13 (1.5) | 13 (100) | 13 (100) | 3 (23) | 10 (77) | |
VI | 20 (2.4) | 20 (100) | 20 (100) | 0 (0) | 20 (100) | |
Total | 840 (100) | 197 (23.5) | 172 (20.5) | 123 (71.5) | 49 (28.5) | |
TBSRTC 2017 (2017–2019) | ||||||
II | 1246 (88.8) | 189 (15.2) | 171 (13.7) | 167 (97.7) | 4 (2.3) | 0 (0) |
III | 32 (2.3) | 19 (59.4) | 19 (59.4) | 11 (57.9) | 6 (31.6) | 2 (10.5) |
IV | 83 (5.9) | 74 (89.2) | 74 (89.2) | 50 (67.5) | 19 (25.7) | 5 (6.8) |
V | 25 (1.8) | 25 (100) | 24 (96) | 5 (20.8) | 18 (75) | 1 (4.2) |
VI | 17 (1.2) | 17 (100) | 17 (100) | 0 (0) | 17 (100) | 0 (0) |
Total | 1403 (100) | 324 (23.1) | 305 (21.7) | 233 (76.4) | 64 (21) | 8 (2.6) |
FNA, fine needle aspiration; FP, follicular proliferation; NA: non-applicable; NIFTP, non-invasive follicular thyroid neoplasm with papillary-like nuclear features; TBSRCT, The Bethesda System for Reporting Thyroid Cytopathology.